(Q43506076)

24 November 2017

title

Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans (English)

1 reference

24 November 2017

0 references

G Plewe

1

1 reference

24 November 2017

U Schneider

series ordinal

2

1 reference

24 November 2017

U Krause

series ordinal

3

1 reference

24 November 2017

J Beyer

series ordinal

4

1 reference

24 November 2017

publication date

1 April 1987

1 reference

Journal of Endocrinological Investigation

24 November 2017

published in

1 reference

24 November 2017

volume

10

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

137-141

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03347177

24 November 2017

exact match

0 references

cites work

The endocrinology of the opiates and opioid peptides

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Hormonal and metabolic responses to an enkephalin analogue in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Failure of naloxone to influence physiological growth hormone and prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Effects of naloxone on prolactin, luteinizing hormone, and cortisol responses to surgical stress in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

The role of opioid peptides in the hormonal responses to acute exercise in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Impaired hypothalamic control of prolactin secretion in massive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Altered hypothalamic and sympathetic responses to hypoglycaemia in familial obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

beta-Endorphin and beta-lipotropin plasma levels in hirsute women: correlation with body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

beta-Endorphin stimulates the secretion of insulin and glucagon in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Impulsive and basal ACTH secretion phases in normal subjects, in obese subjects with signs of adrenocortical hyperfunction and in hyperthyroid patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Prolonged elevation of hypothalamic opioid peptide activity in women taking oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Naloxone effects on serum growth hormone and prolactin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary Gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Endogenous opioid modulation of pancreatic hormone secretion: studies in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347177

Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids

21 January 2018

1 reference

12 December 2020

Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *

1 reference

12 December 2020

Lack of Modulation of Pituitary Hormone Stress Response by Neural Pathways Involving Opiate Receptors*

1 reference

12 December 2020

Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia

1 reference

12 December 2020

Studies off the opiate control of prolactin, GH and TSH

1 reference

12 December 2020

Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man

1 reference

12 December 2020

Hyperendorphinemia in obese children and adolescents

1 reference

12 December 2020

Effects of Exogenous βh-Endorphin on Pituitary Hormone Secretionand Its Disappearance Rate in Normal Human Subjects*

1 reference

12 December 2020

Simultaneous pulsatile release of prolactin and luteinizing hormone induced by luteinizing hormone-releasing factor agonist

1 reference

12 December 2020

Naloxone effects on ?-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers

1 reference

12 December 2020

Classification of opioid receptors

1 reference

12 December 2020

Cortisol secretion rate and urinary corticoid excretion in normal and obese subjects

1 reference

12 December 2020

Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion

1 reference

12 December 2020

Effect of arginine on serum levels of insulin and growth hormone in obese subjects

1 reference

12 December 2020

Naloxone inhibits exercise-induced release of PRL and GH in athletes

1 reference

12 December 2020

Failure of naloxone to alter exercise-induced growth hormone and prolactin release in normal men

1 reference

12 December 2020

Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347177

1 reference

Dimensions Publication ID

24 November 2017

1043486608

0 references

1 reference